Conference
Impact of Concomitant Use of Disease Modifying Antirheumatic Drugs and Methotrexate Administration Route on Durability of Biologic Treatment: Results from the Ontario Best Practice Research Initiative (OBRI) Cohort
Authors
Lau A; Thorne C; Movahedi M; Cesta A; Li X; Couto S; Sampalis J; Rampakakis E; Bombardier C
Volume
44
Pagination
pp. 873-873
Publisher
J RHEUMATOL PUBL CO
Publication Date
June 1, 2017
Name of conference
72nd Annual Meeting of the Canadian-Rheumatology-Association (CRA)
Conference place
Ottawa, CANADA
Conference start date
February 8, 2017
Conference end date
February 11, 2017
Conference proceedings
JOURNAL OF RHEUMATOLOGY
Issue
6
ISSN
0315-162X